US Patent 7868035 Therapeutic esters

Patent 7868035 was granted and assigned to Allergan, Inc. on January, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78680350

Patent Inventor Names

David F. Woodward0

Robert M. Burk0

Date of Patent

January 11, 2011

Patent Application Number

118148150

Date Filed

January 31, 2006

Patent Citations Received

‌

US Patent 12016841 Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders

‌

US Patent 11976044 Highly pure phentolamine mesylate

Patent Primary Examiner

‌

Rebecca L Anderson

Patent abstract

A compound comprising

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7868035 Therapeutic esters

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API